Jankovic J - Search Results

1

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM; Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators. Frank S, et al. Among authors: jankovic j. JAMA Neurol. 2017 Aug 1;74(8):977-982. doi: 10.1001/jamaneurol.2017.1352. JAMA Neurol. 2017. PMID: 28692723 Free PMC article.

2

Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.

Deng H, Le WD, Hunter CB, Ondo WG, Guo Y, Xie WJ, Jankovic J. Deng H, et al. Among authors: jankovic j. Arch Neurol. 2006 Feb;63(2):273-7. doi: 10.1001/archneur.63.2.273. Arch Neurol. 2006. PMID: 16476817

3

Is history of depression a contraindication to treatment with tetrabenazine?

Kenney C, Hunter C, Mejia N, Jankovic J. Kenney C, et al. Among authors: jankovic j. Clin Neuropharmacol. 2006 Sep-Oct;29(5):259-64. doi: 10.1097/01.WNF.0000228369.25593.35. Clin Neuropharmacol. 2006. PMID: 16960470 Clinical Trial.

4

Botulinum toxin injection for congenital muscular torticollis presenting in children and adults.

Collins A, Jankovic J. Collins A, et al. Among authors: jankovic j. Neurology. 2006 Sep 26;67(6):1083-5. doi: 10.1212/01.wnl.0000237336.65596.21. Neurology. 2006. PMID: 17000985 Clinical Trial.

5

Short-term effects of tetrabenazine on chorea associated with Huntington's disease.

Kenney C, Hunter C, Davidson A, Jankovic J. Kenney C, et al. Among authors: jankovic j. Mov Disord. 2007 Jan;22(1):10-3. doi: 10.1002/mds.21161. Mov Disord. 2007. PMID: 17078062 Clinical Trial.

6

Genetic analysis of LRRK2 mutations in patients with Parkinson disease.

Deng H, Le W, Guo Y, Hunter CB, Xie W, Huang M, Jankovic J. Deng H, et al. Among authors: jankovic j. J Neurol Sci. 2006 Dec 21;251(1-2):102-6. doi: 10.1016/j.jns.2006.09.017. Epub 2006 Nov 9. J Neurol Sci. 2006. PMID: 17097110

7

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Hunter C, Jankovic J. Kenney C, et al. Among authors: jankovic j. Mov Disord. 2007 Jan 15;22(2):193-7. doi: 10.1002/mds.21222. Mov Disord. 2007. PMID: 17133512

8

A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations.

Deng H, Le WD, Hunter CB, Mejia N, Xie WJ, Jankovic J. Deng H, et al. Among authors: jankovic j. Arch Neurol. 2007 Mar;64(3):421-4. doi: 10.1001/archneur.64.3.421. Arch Neurol. 2007. PMID: 17353387

9

Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.

Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J. Kenney C, et al. Among authors: jankovic j. J Neurosurg. 2007 Apr;106(4):621-5. doi: 10.3171/jns.2007.106.4.621. J Neurosurg. 2007. PMID: 17432713

10

Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson disease.

Jankovic J, Watts RL, Martin W, Boroojerdi B. Jankovic J, et al. Arch Neurol. 2007 May;64(5):676-82. doi: 10.1001/archneur.64.5.676. Arch Neurol. 2007. PMID: 17502466 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,253 results

Search Page

Filters